Healthcare Capital Corp.
HCCCU
NASDAQ Capital Market12.88
USD
+1.48
- -
Healthcare Capital Corp.
HCCCU
(NASDAQ Capital Market)
Recent
price
12.88
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Healthcare Capital Corp. (NasdaqCM:HCCCU) operates as a blank check company, or special purpose acquisition company (SPAC), formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily targeting innovative companies in the healthcare sector including digital health, telehealth, life sciences, innovative medical devices, and healthcare technology; it offers no current products or services beyond this acquisition vehicle. The company, founded in 2020 and headquartered in Wilmington, Delaware, completed an upsized initial public offering in January 2021 raising $275 million through the sale of 27.5 million units at $10 each, underwritten by Cantor Fitzgerald & Co., with units comprising one share of Class A common stock and one-half of a redeemable warrant exercisable at $11.50. In March 2022, Healthcare Capital Corp. was acquired by Alpha Tau Medical Ltd. in a reverse merger transaction, providing Alpha Tau approximately $90 million in gross cash proceeds to advance its Alpha DaRT radiation therapy for solid tumors, with the combined entity listing on Nasdaq under the symbol DRTS; units continue to trade as of late 2025 with no further major developments, partnerships, funding rounds, or strategic shifts reported in the last 1-2 years.
Healthcare Capital Corp. Announces Pricing of Upsized $240 Million Initial Public Offering